Journal of Modern Chemistry & Chemical Technology Original Research

Smart Nanomaterials for Targeted Drug Delivery: Properties, Functionalization and Biomedical Applications

  1. Aastha Sharma Department of Chemistry, NSCBM Govt. College, Hamirpur
  2. Ashita Garg Department of Chemistry, NSCBM Govt. College, Hamirpur
  3. Samjeet Singh Thakur Department of Chemistry, NSCBM Govt. College, Hamirpur

Abstract

Targeted drug delivery has become an important area of research in modern pharmaceutical and biomedical sciences. Traditional drug delivery methods often suffer from several limitations such as poor bioavailability, non-specific distribution of drugs and undesirable side effects caused by the exposure of healthy tissues to therapeutic agents. In recent years, nanotechnology has provided innovative solutions to overcome these challenges through the development of smart nanomaterials capable of delivering drugs directly to specific sites in the body. These nanomaterials possess unique physicochemical properties such as small size, high surface area, and the ability to respond to different biological stimuli. The objective is to examine the role of smart nanomaterials in targeted drug delivery and to discuss their mechanisms, types, applications, and recent research developments. Various smart nanocarriers including liposome, polymeric nanoparticles, dendrimers, gold nanoparticles and magnetic nanoparticles have shown significant potential in improving the efficiency and selectivity of drug delivery systems. These materials can be designed to respond to internal stimuli such as pH, enzymes, and redox conditions or external stimuli such as temperature, light and magnetic fields, enabling controlled and site-specific drug release. Recent studies indicate that smart nanomaterials significantly enhance therapeutic efficacy while minimizing systemic toxicity. They have demonstrated promising applications in the treatment of cancer, neurological disorders, and infectious diseases by enabling precise drug targeting and controlled release. Despite certain challenges related to toxicity, stability, and large-scale production, the development of smart nanomaterials represents a major advancement in modern medicine. Overall, the integration of nanotechnology with drug delivery systems has a potential to revolutionize therapeutic strategies and contribute to the development of safer, more effective, and personalized treatment approaches in the future.

Keywords

References (87)

  1. Iqbal, H. M. N., Rodriguez, A. M. V., Khandia, R., Munjal, A., & Dhama, K. (2017). Recent trends in nanotechnology-based drugs and formulations for targeted therapeutic delivery. Recent Patents on Inflammation & Allergy Drug Discovery, 10(2), 86–93. https://doi.org/10.2174/1872213X10666161213162823
  2. Abdellatif, A. A., Mohammed, H. A., Khan, R. A., Singh, V., Bouazzaoui, A., Yusuf, M., ... & Al-Omar, M. S. (2021). Nano-scale delivery: A comprehensive review of nano-structured devices, preparative techniques, site-specificity designs, biomedical applications, commercial products, and references to safety, cellular uptake, and organ toxicity. Nanotechnology Reviews, 10(1), 1493-1559.
  3. Lombardo, D., Kiselev, M. A., & Caccamo, M. T. (2019). Smart nanoparticles for drug delivery application: development of versatile nanocarrier platforms in biotechnology and nanomedicine. Journal of nanomaterials, 2019(1), 3702518.
  4. Gullotti, E., & Yeo, Y. (2009). Extracellularly activated nanocarriers: A new paradigm of tumor targeted drug delivery. Molecular Pharmaceutics, 6(4), 1041–1051. https://doi.org/10.1021/mp900090z
  5. Jain RK. Barriers to drug delivery in solid tumors. Scientific American. 1994 Jul 1;271(1):58-65.
  6. Kelkar, S. S., & Reineke, T. M. (2011). Theranostics: combining imaging and therapy. Bioconjugate chemistry, 22(10), 1879-1903.
  7. Malik, S., Muhammad, K., & Waheed, Y. (2023). Emerging applications of nanotechnology in healthcare and medicine. Molecules, 28(18), 6624.
  8. Medical illustration of a DNA double helix emerging from a pill capsule]. (n.d.). PLOS DNA Science.
  9. Bozzuto, G., & Molinari, A. (2015). Liposomes as nanomedical devices. International journal of nanomedicine, 975-999.
  10. Tomalia, D. A., Christensen, J. B., & Boas, U. (2012). Dendrimers, dendrons, and dendritic polymers: discovery, applications, and the future. Cambridge University Press.
  11. Alvarez-Lorenzo, C., &Concheiro, A. (2014). Smart drug delivery systems: from fundamentals to the clinic. Chemical communications, 50(58), 7743-7765.
  12. Choi, K. Y., Liu, G., Lee, S., & Chen, X. (2012). Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives. Nanoscale, 4(2), 330-342.
  13. Sharma, R., Sharma, K. S., & Kumar, D. (2022). Introduction to nanotechnology. Nanomaterials in Clinical Therapeutics: Synthesis and Applications, 1-31.
  14. Mekuye, B., & Abera, B. (2023). Nanomaterials: An overview of synthesis, classification, characterization, and applications. Nano selects, 4(8), 486-501.
  15. Asha, A. B., & Narain, R. (2020). Nanomaterials properties. In Polymer science and nanotechnology (pp. 343-359). Elsevier.
  16. Mitchell, M. J., Billingsley, M. M., Haley, R. M., Wechsler, M. E., Peppas, N. A., & Langer, R. (2021). Engineering precision nanoparticles for drug delivery. Nature reviews drug discovery, 20(2), 101-124.
  17. Goldberg, M., Langer, R., & Jia, X. (2007). Nanostructured materials for applications in drug delivery and tissue engineering. Journal of Biomaterials Science, Polymer Edition, 18(3), 241-268.
  18. Thakor, A. S., & Gambhir, S. S. (2013). Nanooncology: the future of cancer diagnosis and therapy. CA: a cancer journal for clinicians, 63(6), 395-418.
  19. Vagena, I. A., Malapani, C., Gatou, M. A., Lagopati, N., &Pavlatou, E. A. (2025). Enhancement of EPR effect for passive tumor targeting:current status and future perspectives. Applied Sciences, 15(6), 3189.
  20. Petrovic, S. M., &Barbinta-Patrascu, M. E. (2023). Organic and biogenic nanocarriers as bio-friendly systems for bioactive compounds’ delivery: state-of-the art and challenges. Materials, 16(24), 7550.
  21. Xia, B., Liu, Y., Xing, Y., Shi, Z., & Pan, X. (2025). Biodegradable medical implants: Reshaping future medical practice. Advanced Science, 12(35), e08014. https://doi.org/10.1002/advs.202508014
  22. Burlec, A. F., et al. (2023). Current overview of metal nanoparticles' synthesis, characterization, and biomedical applications, with a focus on silver and gold nanoparticles. Pharmaceuticals, 16(10), 1410. https://doi.org/10.3390/ph16101410
  23. Akbarzadeh, A., Rezaei-Sadabady, R., Davaran, S., Joo, S. W., Zarghami, N., Hanifehpour, Y., ... &Nejati-Koshki, K. (2013). Liposome: classification, preparation, and applications. Nanoscale research letters, 8(1), 102.
  24. Khodadadi, E., Khodadadi, E., Chaturvedi, P., & Moradi, M. (2025). Molecular Dynamics Simulations of Liposomes: Structure, Dynamics, and Applications. Membranes, 15(9), 259.
  25. Structure of dipalmitoylphosphatidylcholine (DPPC). From Dipalmitoylphosphatidylcholine, DPPC molecule. Natural phospholipid present in pulmonary surfactant. Structural chemical formula, dark blue background by Bacsica, 2025, Shutterstock.
  26. Beach, M. A., Nayanathara, U., Gao, Y., Zhang, C., Xiong, Y., Wang, Y., & Such, G. K. (2024). Polymeric nanoparticles for drug delivery. Chemical reviews, 124(9), 5505-5616.
  27. Abbasi, E., Aval, S. F., Akbarzadeh, A., Milani, M., Nasrabadi, H. T., Joo, S. W., ... & Pashaei-Asl, R. (2014). Dendrimers: synthesis, applications, and properties. Nanoscale research letters, 9(1), 247.
  28. Lyu, Z., Ding, L., Huang, A. T., Kao, C. L., & Peng, L. (2019). Poly (amidoamine) dendrimers: Covalent and supramolecular synthesis. Materials Today Chemistry, 13, 34-48.
  29. Mohammadi, M. J., Khaniabadi, Y. O., & Yari, A. R. (2018). The antibacterial effect of G3-poly-amidoamine dendrimer on gram negative and gram positive bacteria in aqueous solutions. Desalination and Water Treatment, 123, 131–139. doi.org
  30. Alshammari, B. H., Lashin, M. M., Mahmood, M. A., Al-Mubaddel, F. S., Ilyas, N., Rahman, N., ... & Khan, R. (2023). Organic and inorganic nanomaterials: fabrication, properties and applications. RSC advances, 13(20), 13735-13785.
  31. Croitoru, G.-A., Pîrvulescu, D.-C., Niculescu, A. G., & Nicolae, C.-L. (2024). Metallic nanomaterials – targeted drug delivery approaches for improved bioavailability, reduced side toxicity, and enhanced patient outcomes. Romanian Journal of Morphology and Embryology, 65(2).
  32. Amendola, V., Pilot, R., Frasconi, M., Maragò, O. M., &Iatì, M. A. (2017). Surface plasmon resonance in gold nanoparticles: a review. Journal of physics: Condensed matter, 29(20), 203002.
  33. Kankala, R. K., Han, Y. H., Na, J., Lee, C. H., Sun, Z., Wang, S. B., ... & Wu, K. C. W. (2020). Nanoarchitectured structure and surface biofunctionality of mesoporous silica nanoparticles. Advanced materials, 32(23), 1907035.
  34. Narayan, R., Nayak, U. Y., Raichur, A. M., & Garg, S. (2018). Mesoporous silica nanoparticles: A comprehensive review on synthesis and recent advances. Pharmaceutics, 10(3), 118.
  35. Pechnikova, N. A., Poimenidou, M., Patsidou, C., Zafeiriou-Chatziefraimidou, M., Iliadis, I., & Yaremenko, A. V. (2026). Engineered nanoparticles for combating drug-resistant bacteria and bacterial biofilms. ACS Nano Medicine, 1(3), 492–546. https://doi.org/10.1021/acsnanomed.5c00060
  36. Image generated using the prompt "Scientific diagram illustrating functionalization of a mesorous silica nanoparticle with APTES" by Open AI, DALL-E 3, 2026
  37. Anitha Rose, T. J., Rupesh Kumar Reddy, B., Vasundhara, S., & Narasimha, G. (2025). Nanotechnology and its role in seed technology. SAS International Journal of Plant and Agricultural Sciences, 11
  38. Pham, S. H., Choi, Y., & Choi, J. (2020). Stimuli-responsive nanomaterials for application in antitumor therapy and drug delivery. Pharmaceutics, 12(7), 630.
  39. Zhang, Y., & Wu, B. M. (2023). Current advances in stimuli-responsive hydrogels as smart drug delivery carriers. Gels, 9(10), 838.
  40. Feng, L., Dong, Z., Tao, D., Zhang, Y., & Liu, Z. (2018). The acidic tumor microenvironment: a target for smart cancer nano-theranostics. National Science Review, 5(2), 269-286.
  41. Bodagala, S. R., & Samathoti, P. (2026). Synthesis and molecular characterization of a novel FA-ADH-GMS conjugated pH-responsive lipid for targeted drug delivery. Molecular Diversity. Advance online publication. https://doi.org/10.1007/s11030-026-11562-x
  42. Karimi, M., SahandiZangabad, P., Ghasemi, A., Amiri, M., Bahrami, M., Malekzad, H., ... & Hamblin, M. R. (2016). Temperature-responsive smart nanocarriers for delivery of therapeutic agents: applications and recent advances. ACS applied materials & interfaces, 8(33), 21107-21133.
  43. Sun, W., Hu, Q., Ji, W., Wright, G., & Gu, Z. (2016). Leveraging physiology for precision drug delivery. Physiological reviews.
  44. Huang, J., Li, Y., Orza, A., Lu, Q., Guo, P., Wang, L., ... & Mao, H. (2016). Magnetic nanoparticle facilitated drug delivery for cancer therapy with targeted and image‐guided approaches. Advanced functional materials, 26(22), 3818-3836.
  45. Sung, B., Shaffer, S., Sittek, M., Alboslemy, T., Kim, C., & Kim, M.-H. (2016). Alternating magnetic field-responsive hybrid gelatin microgels for controlled drug release. Journal of Visualized Experiments, (108), e53680. doi.org
  46. Linsley, C. S., & Wu, B. M. (2017). Recent advances in light-responsive on-demand drug-delivery systems. Therapeutic delivery, 8(2), 89-107.
  47. Nasir, A., Kausar, A., & Younus, A. (2015). A review on preparation, properties and applications of polymeric nanoparticle-based materials. Polymer-Plastics Technology and Engineering, 54(4), 325-341.
  48. Miladi, K., Sfar, S., Fessi, H., &Elaissari, A. (2017). Nanoprecipitation process: from particle preparation to in vivo applications. In Polymer Nanoparticles for Nanomedicines: A Guide for their Design, Preparation and Development (pp. 17-53). Cham: Springer International Publishing.
  49. Fernandes, D. A. (2025). Nanoparticles for cancer gene therapy and imaging. Biomedical Materials & Devices, 3, 967–1029. https://doi.org/10.1007/s44174-024-00235-8
  50. Yadav, T. P., Yadav, R. M., & Singh, D. P. (2012). Mechanical milling: a top down approach for the synthesis of nanomaterials and nanocomposites. Nanoscience and Nanotechnology, 2(3), 22-48.
  51. Yong, A. P., Islam, M. A., & Hasan, N. (2017). A review: Effect of pressure on homogenization. Sigma Journal of Engineering and Natural Sciences, 35(1), 1-22.
  52. Singh, J., Dutta, T., Kim, K. H., Rawat, M., Samddar, P., & Kumar, P. (2018). ‘Green’synthesis of metals and their oxide nanoparticles: applications for environmental remediation. Journal of nanobiotechnology, 16(1), 84.
  53. Genizer LLC. (n.d.). Nanogenizer lab high pressure homogenizer.
  54. Deirram, N., Zhang, C., Kermaniyan, S. S., Johnston, A. P. R., & Such, G. K. (2020). Strategies to obtain encapsulation and controlled release of small hydrophilic molecules. Frontiers in Bioengineering and Biotechnology, 8, Article 437. doi.org.
  55. Masarudin, M. J., Cutts, S. M., Evison, B. J., Phillips, D. R., & Pigram, P. J. (2015). Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [14C]-doxorubicin. Nanotechnology, science and applications, 67-80.
  56. Elzoghby, A. O., Samy, W. M., &Elgindy, N. A. (2012). Albumin-based nanoparticles as potential controlled release drug delivery systems. Journal of controlled release, 157(2), 168-182.
  57. Haidar, L. L., Bilek, M., & Akhavan, B. (2024). Surface Bio‐engineered Polymeric Nanoparticles. Small, 20(21), 2310876.
  58. Paul, J., Govindaraju, R., & Kim, J. (2026). Folic acid functionalized exopolysaccharide integrated into a coordination polymer for targeted and controlled drug release. Carbohydrate Polymers, 125127.
  59. Li, Jianmin & Wang, Qingluo& Xia, Guoyu &Adilijiang, Nigela& Li, Ying & Hou, Zhenqing& Fan, Zhongxiong& Li, Jinyao. (2023). Recent Advances in Targeted Drug Delivery Strategy for Enhancing Oncotherapy. Pharmaceutics. 15. 2233.
  60. Attia, M. F., Anton, N., Wallyn, J., Omran, Z., & Vandamme, T. F. (2019). An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites. Journal of Pharmacy and Pharmacology, 71(8), 1185-1198.
  61. Cheng, W., Zeng, X., Chen, H., Li, Z., Zeng, W., Mei, L., & Zhao, Y. (2019). Versatile polydopamine platforms: synthesis and promising applications for surface modification and advanced nanomedicine. ACS nano, 13(8), 8537-8565.
  62. (2024). Enhanced permeation and retention (EPR) effect in tumor tissues [Image].
  63. Sawant, J., & Patel, R. (2023). Molecular mechanisms of antibody-dependent enhancement in viral infections. Journal of Virology, 11(7), 1240. doi.org
  64. From a physical organic chemistry perspective, this ligand-receptor recognition is governed by a cascade of highly coordinated, localized non-covalent intermolecular forces.
  65. Kamaly, N., Yameen, B., Wu, J., &Farokhzad, O. C. (2016). Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release. Chemical reviews, 116(4), 2602-2663.
  66. Sun, L., Liu, H., Ye, Y., Lei, Y., Islam, R., Tan, S., ... & Cai, L. (2023). Smart nanoparticles for cancer therapy. Signal transduction and targeted therapy, 8(1), 418.
  67. Wu, D., Chen, Q., Chen, X., Han, F., Chen, Z., & Wang, Y. (2023). The blood–brain barrier: Structure, regulation and drug delivery. Signal transduction and targeted therapy, 8(1), 217.
  68. Dominguez, M. (2020, February 13). Blood-brain barrier. Medbullets Step 1.
  69. Hetta, H. F., Ramadan, Y. N., Al-Harbi, A. I., A. Ahmed, E., Battah, B., Abd Ellah, N. H., ... &Donadu, M. G. (2023). Nanotechnology as a promising approach to combat multidrug resistant bacteria: a comprehensive review and future perspectives. Biomedicines, 11(2), 413.
  70. Mollé, L. M., Smyth, C. H., Yuen, D., & Johnston, A. P. (2022). Nanoparticles for vaccine and gene therapy: Overcoming the barriers to nucleic acid delivery. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 14(6), e1809.
  71. Lammers T. Smart drug delivery systems: back to the future vs. clinical reality. International journal of pharmaceutics. 2013 Sep 15;454(1):527-9.
  72. Sharifi, S., Behzadi, S., Laurent, S., Forrest, M. L., Stroeve, P., & Mahmoudi, M. (2012). Toxicity of nanomaterials. Chemical Society Reviews, 41(6), 2323-2343.
  73. Aljabali, A. A., Obeid, M. A., Bashatwah, R. M., Serrano-Aroca, Á., Mishra, V., Mishra, Y., ... &Tambuwala, M. M. (2023). Nanomaterials and their impact on the immune system. International journal of molecular sciences, 24(3), 2008.
  74. Liu, D., Yang, F., Xiong, F., & Gu, N. (2016). The smart drug delivery system and its clinical potential. Theranostics, 6(9), 1306.
  75. Taube, P. S., Fernandes, D., Vasconcelos, A. A., Braga, H. D. C., Lima, A. K. O., Costa, J. A. S., et al. (2026). Contrast agents for enhanced bioimaging: A comprehensive review. ChemBioChem, 27(13), e70418. https://doi.org/10.1002/cbic.70418
  76. Halvorsen HK. British Nuclear Medicine Society Spring Meeting 20th-22nd April 2026. Nuclear Medicine Communications. 2026 Apr;47(7):849-903.
  77. Wu S, Lin L, Shi L, Liu S. An overview of lipid constituents in lipid nanoparticle mRNA delivery systems. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology. 2024 Jul;16(4):e1978.
  78. Mazumdar, H., Khondakar, K. R., Das, S., Halder, A., & Kaushik, A. (2025). Artificial intelligence for personalized nanomedicine; from material selection to patient outcomes. Expert Opinion on Drug Delivery, 22(1), 85-108.
  79. Stanislawska, I., Liwinska, W., Lyp, M., Stojek, Z., &Zabost, E. (2019). Recent advances in degradable hybrids of biomolecules and NGs for targeted delivery. Molecules, 24(10), 1873.
  80. Tenchov, R., Bird, R., Curtze, A. E., & Zhou, Q. (2021). Lipid nanoparticles─ from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement. ACS nano, 15(11), 16982-17015.
  81. Ruenraroengsak, P., Cook, J. M., & Florence, A. T. (2010). Nanosystem drug targeting: facing up to complex realities. Journal of Controlled Release, 141(3), 265-276.
  82. Mangla, B., Kumar, P., Javed, S., Pathan, T., Ahsan, W., & Aggarwal, G. (2025). Regulating nanomedicines: challenges, opportunities, and the path forward. Nanomedicine, 20(15), 1911-1927.
  83. Saratale, R. G., Saratale, G. D., Shin, H. S., Jacob, J. M., Pugazhendhi, A., Bhaisare, M., & Kumar, G. (2018). New insights on the green synthesis of metallic nanoparticles using plant and waste biomaterials: current knowledge, their agricultural and environmental applications. Environmental Science and Pollution Research, 25(11), 10164-10183.
  84. Alghamdi, M. A., Fallica, A. N., Virzì, N., Kesharwani, P., Pittalà, V., &Greish, K. (2022). The promise of nanotechnology in personalized medicine. Journal of personalized medicine, 12(5), 673.
  85. Lammers, T., Aime, S., Hennink, W. E., Storm, G., & Kiessling, F. (2011). Theranostic nanomedicine. Accounts of chemical research, 44(10), 1029-1038.
  86. Rajendran, S., Sundararajan, P., Awasthi, A., & Rajendran, S. (2023). Nanorobotics in medicine: A systematic review of advances, challenges, and future prospects. arXiv preprint arXiv:2309.10881.
  87. Unnithan, D., Sartaj, A., Iqubal, M. K., Ali, J., &Baboota, S. (2024). A neoteric annotation on the advances in combination therapy for Parkinson’s disease: nanocarrier-based combination approach and future anticipation. Part II: nanocarrier design and development in focus. Expert opinion on drug delivery, 21(3), 437-456.

Read more of it

Subscribe to one journal or build your own list of several. One invoice, one payment, access for a full year.

Subscribe to journals →

Publish your article

Peer-reviewed journals across every subject, with open access options. Send your manuscript to the right editor today.

Publish with us → Calculate your APC
Support